Following the rapid increase of customer orders in Asia, the current production site of Sanner Pharmaceutical & Medical Packaging Materials (Kunshan) Co., Ltd. (Sanner of China) is reaching the upper limits of its capacities. Hence, the company decided to build a second production site near to the existing one in Kunshan.
The land transaction process is expected to be completed in August, and construction will start in September 2021. The new production site will be put into operation before the end of next year.
The new site will feature additional 3,000 m2 (approximately 32,300 sq. ft) of cleanroom production facilities. Moreover, the site will be equipped with a GMP warehouse, a mould assembly and maintenance workshop, auxiliary equipment, as well as an office area.
According to Ralf Tiemann, CEO Asia Pacific at Sanner, the new Kunshan site will include a "a high degree of automation" to meet demanding customers requirements.
Apart from more production space for the existing portfolio, the site will also provide additional capacities for research, development, and production of Sanner’s new products, such as customised pharmaceutical primary packaging or intelligent medtech solutions. “2020 was again a highly successful year for Sanner. With around €35 million of annual sales, Sanner of China contributed significantly to the record sales result of the entire Sanner group,” Tiemann underlines. “We will achieve the next milestone with the inauguration of our new production site. With the new facility, we will have the ability to increase production output by 80%.”